NEW YORK, Feb. 01, 2017 -- MSG Networks Inc. (NYSE:MSGN) announced today that it has reached an agreement with the National Hockey League (NHL) for live streaming rights to New York Rangers, New Jersey Devils, New York Islanders and Buffalo Sabres games. In the coming weeks, MSG Networks’ unmatched lineup of exclusive local live NHL hockey games will be made available to customers of participating operators on MSG GO -- MSG Networks’ live streaming and on demand product.
“As the outlet for more live local NHL games than any other RSN in the country, we are pleased to partner with the NHL and our teams to provide hockey fans with additional ways to view our games,” said Andrea Greenberg, president and chief executive officer, MSG Networks. “With the addition of the NHL, MSG GO will certainly be a premiere mobile destination for hockey fans in the region.”
“With this agreement, MSG Networks once again demonstrates what it means to be an excellent partner for our clubs,” said David Proper, executive vice president, media and international strategy, NHL. “Together we share a vision for serving our fans, who are extremely passionate about their teams. This agreement for live streaming on MSG GO is all about fulfilling demand and providing our fans with the type of access they want in the way that is most convenient to them.”
In addition to MSG Networks’ live, professional game coverage, MSG GO includes pre- and postgame shows, as well as episodes of MSG Networks’ award-winning programming. With MSG GO, fans are able to access upcoming schedules, and set reminders on their personal devices for games on MSG Networks.
MSG GO is currently available at no charge to subscribers of participating television providers who receive MSG Networks as part of their pay television subscription. Subscribers with a supported smartphone or tablet can download the free MSG GO app by visiting the App Store or the Google Play store. On computers, customers may visit MSGGo.com.
About MSG Networks Inc.
An industry leader in sports production, and content development and distribution, MSG Networks Inc. owns and operates two award-winning regional sports and entertainment networks, MSG Network (MSG) and MSG+, and a live streaming and video on demand platform, MSG GO. The networks are home to 10 professional sports teams, delivering live games of the New York Knicks; New York Rangers; New York Islanders; New Jersey Devils; Buffalo Sabres; New York Liberty; New York Red Bulls and the Westchester Knicks, as well as coverage of the New York Giants and Buffalo Bills. Each year, MSG and MSG+ collectively telecast approximately 500 live professional games, along with a comprehensive lineup of other sporting events, including college football and basketball, and critically-acclaimed original programming. The gold standard for regional broadcasting, MSG Networks has won 145 New York Emmy Awards over the past nine years.
Dan Schoenberg / 212-465-6367 Alyssa Ross / 212-324-3401 Bill Hanousek / 212-465-6591


Jefferies Names AMEC Top China Semiconductor Equipment Pick
Amazon Secures 200 MW Wind Power Deals in Sweden
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 



